Normative Reference Values for the FACE-Q Skin Cancer Module: Patient Preoperative Scores and Comparison With Healthy Partners

This study establishes normative reference values for the FACE-Q Skin Cancer Module by demonstrating that preoperative scores of facial skin cancer patients are statistically equivalent to those of demographically matched healthy partners, thereby validating the module's utility for clinical interpretation while highlighting a specific sex-based difference in appearance scores.

The Gist

Imagine you have a thermometer. If you see a reading of 100°F, you know immediately that something is wrong because you have a "normal" baseline to compare it against. But what if you were trying to measure something new, like a person's emotional or physical "facial health," and you didn't have a thermometer? You wouldn't know if a score of 50 was a disaster or just a bad day.

That is exactly the problem this paper solves for people with facial skin cancer.

The Problem: A Ruler Without Numbers

The FACE-Q Skin Cancer Module is like a very sophisticated ruler designed to measure how people feel about their face and how much stress skin cancer causes them. Doctors and researchers have already proven that this ruler is accurate (it measures what it's supposed to measure).

However, until now, the ruler had no numbers on it. If a patient said, "I feel a 40 on the stress scale," the doctor would have to guess: Is that high? Is that low? Is that normal for someone with cancer, or is it actually quite good? Without a "normative reference" (a standard baseline), the scores were just floating numbers without context.

The Experiment: The "Look-Alike" Test

To build a proper scale, the researchers needed a control group. They couldn't just compare cancer patients to the general public because cancer patients are often older or have different lifestyles.

So, they came up with a clever idea: The Partner Test.
They gathered 287 patients about to have facial skin cancer surgery. Then, they found 82 healthy people who were the partners (spouses, friends, or family) of those patients. These partners were the perfect "look-alikes": they were the same age, mostly the same gender, and lived in the same environment. They were the "healthy twins" of the patient group.

The Surprise: The "Mirror" Effect

The researchers expected the cancer patients to feel terrible about their faces and be very stressed, while the healthy partners would feel great. They expected a huge gap between the two groups.

But the results were shocking.

It was like looking into a mirror. The patients about to have surgery had virtually identical scores to their healthy partners.

• Appearance: Both groups rated their facial appearance around the same level (about 55 out of 100).
• Stress: Both groups reported the same level of worry and distress (about 14 out of 100).

It turns out that having facial skin cancer before surgery doesn't automatically make you feel like your face is ruined or that you are in a panic. The "healthy" partners were just as worried or satisfied as the patients.

The One Exception: The Gender Twist

There was one small crack in the mirror. When they looked specifically at women, the female patients felt slightly worse about their appearance than their female partners did. However, for men, there was no difference at all. It's as if the "cancer worry" hit women a tiny bit harder regarding how they looked, but men were unaffected by the diagnosis in terms of self-image.

Why This Matters: The New "Thermometer"

The most important takeaway is that the researchers successfully created a standardized map (normative values).

Now, when a doctor sees a patient's score, they can say:

"Your score is in the 10th percentile. This means you are feeling worse than 90% of other people with facial skin cancer. We need to help you."

Or:

"Your score is in the 90th percentile. Even though you have cancer, your feelings about your face are actually better than most people in your situation. That's great news."

The Bottom Line

This study gave us a "normal" baseline for facial skin cancer patients. It proved that, surprisingly, these patients often feel just as good (or just as bad) as their healthy friends and spouses. Now, doctors have a reliable tool to track progress, ensuring that when a patient's score does drop, they know exactly when to step in and help.

Technical Summary

Technical Summary: Normative Reference Values for the FACE-Q Skin Cancer Module

1. Problem Statement

The FACE-Q Skin Cancer Module is a validated, condition-specific patient-reported outcome measure (PROM) designed to assess the impact of facial skin cancer on appearance and psychosocial well-being. While the instrument's psychometric properties (reliability and validity) have been previously established, a critical gap exists in clinical practice and research: the lack of normative reference values. Without these benchmarks, clinicians and researchers cannot effectively interpret individual patient scores to determine if a patient's distress or appearance concerns are typical for their demographic or indicative of a specific clinical issue.

2. Methodology

The study employed a comparative cross-sectional design involving two distinct cohorts:

• Patient Cohort: 287 individuals with facial skin cancer, assessed using preoperative scores.
• Control Cohort: 82 healthy partners of the skin cancer patients, serving as a demographically matched "same-age" population without facial skin cancer.

Instrumentation and Data Collection:
Both cohorts completed the Appearance (9 items) and Psychosocial Distress (8 items) scales. The patient cohort additionally completed the Cancer Worry (10 items) and Sun Protection (5 items) scales.

• Scoring: All raw scores were transformed to a standardized 0–100 scale.
• Statistical Analysis:
  • Normative Values: Expressed as percentiles, both overall and stratified by sex and age groups.
  • Group Comparisons: Utilized independent t-tests, Mann-Whitney U tests, and Cohen's d for effect size.
  • Reliability: Internal consistency was evaluated using Cronbach's alpha.

3. Key Contributions

• Establishment of Norms: The study provides the first comprehensive set of normative reference values (percentiles) for the FACE-Q Skin Cancer Module, stratified by sex and age.
• Validation via Healthy Controls: By comparing preoperative patients with healthy partners, the study validates the utility of these scores as a baseline for "normal" population expectations in this specific demographic.
• Sex-Specific Insights: The analysis identified a nuanced sex-based interaction regarding appearance scores, highlighting that gender dynamics may influence self-perception differently in patients versus healthy controls.

4. Key Results

• Demographic Matching: The two cohorts were successfully matched, showing no significant differences in age ($68.6 \pm 11.9$ vs. $68.4 \pm 13.0$, $p=0.902$) or sex distribution ($46.7\%$ vs. $41.5\%$ female, $p=0.476$).
• Score Equivalence (Primary Finding): Contrary to the hypothesis that skin cancer patients would report significantly worse outcomes preoperatively, scores were virtually identical between patients and partners:
  • Appearance: $55.6 \pm 14.0$ (patients) vs. $56.6 \pm 13.6$ (partners); $p=0.590$, Cohen's $d=-0.08$.
  • Psychosocial Distress: $14.3 \pm 12.0$ (patients) vs. $14.4 \pm 13.3$ (partners); $p=0.942$, Cohen's $d=-0.01$.
  • This equivalence persisted across all age groups.
• Sex Interaction: A significant interaction was found regarding sex:
  • Females: Female patients scored significantly lower on appearance ($54.3$) compared to female partners ($59.9$;$p=0.048$, $d=-0.40$).
  • Males: No significant difference was observed between male patients and male partners ($56.9$ vs. $53.1$;$p=0.168$).
• Behavioral Differences: Patients reported marginally higher sun protection behaviors ($38.0$) compared to partners ($33.6$), with a p-value of $0.050$.
• Reliability: Internal consistency was excellent across all scales in both cohorts, with Cronbach's alpha ranging from 0.82 to 0.93.

5. Significance and Implications

• Clinical Utility: The established percentile norms allow clinicians to contextualize individual patient scores. A score can now be interpreted relative to a normative baseline, helping to identify patients who are outliers (e.g., experiencing disproportionate distress) and may require targeted psychological or surgical intervention.
• Research Standardization: Researchers can now use these normative values to benchmark study populations, ensuring that findings regarding facial skin cancer outcomes are comparable across different studies.
• Paradigm Shift in Preoperative Expectations: The finding that preoperative patients report appearance and distress levels similar to healthy individuals suggests that the mere diagnosis of facial skin cancer (prior to surgery) does not automatically degrade self-perception or psychosocial well-being in the general population. This challenges assumptions that preoperative anxiety regarding facial disfigurement is universally high.
• Future Directions: The observed sex-specific difference in appearance scores among females warrants further investigation to understand the underlying psychosocial mechanisms driving this disparity.